In the spotlight: Nestle's Pfizer buy offers long-term baby food boost
Nestle has won through in the battle to acquire Pfizer's baby food business, securing an US$11.85bn deal that will see the world's largest infant nutrition group extend its lead in this fast-growing category. However, with a hefty price tag attached, the deal has not been warmly welcomed by investors. Katy Askew reports.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-food gives you the widest food market coverage.
Paid just-food members have unlimited access to all our exclusive content - including 14 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Dean Best, editor of just-food
- On the money: Spreads, ice cream top Unilever woes
- Why data is key to shopper satisfaction
- Short-termism decides Chiquita's future
- Sustainability Watch: Roberto Ciati, Barilla
- Growth question hangs over refocused Premier
- Glanbia chairman to step down
- General Mills to launch "Ancient Grains" Cheerios
- Hershey lowers FY sales, earnings forecasts
- Mondelez evaluating Oreo production in Morocco
- Kerry rebrands Wall's microwave sausages